Sign in
Subscribe to newsletters Sign in
MENU
Headlines
Increasing number of high cost meds being approved for use in Canada

High-cost, specialty medicines account for an ever-increasing proportion of new treatments coming to market, this according to this year’s annual report from the Patented Medicine Prices Review Board (PMPRB). The Meds Entry Watch, 2018, published

FLASH +1
Diabetes Prevention Clinic reports significant progress
LIFE INSURANCE +2
Bacteria and viruses: Future weapons of warfare
CLIMATE CHANGES +3
Mental health: The social cost of poor mental health
SPECIAL RISKS +3
Canada Life aims to eliminate plastic drug cards
GROUP INSURANCE +6
Advocate sounds alarm about the future availability of new medicines in Canada
GROUP INSURANCE +3
Advertisement
Universal life products comparative table

!function(){"use strict";window.addEventListener("message",function(a){if(void

PERMANENT LIFE +2
SEE MORE
Most read articles
Increasing number of high cost meds being approved for use in Canada
Diabetes Prevention Clinic reports significant progress
Bacteria and viruses: Future weapons of warfare
Mental health: The social cost of poor mental health
Advertisement
Go deeper

TOPICS

Investment Regulation Retirement Mergers and acquisitions Financial planning Technology Wealth management Flash Disciplinary Economy